A turbulent economy and slight cool-down in deal activity early in the year have led some to question whether the record-high valuations for hospice assets will start to tumble.
Like most business sectors, health care has felt the aftershocks of global economic trends such as rising inflation, supply chain disruption, and the continued effects of the COVID-19 pandemic and Russia’s invasion of Ukraine. According to reports and prognosticators, the nation’s crystal balls are swirling with images of a looming recession.
In the midst of this, hospice and home health M&A continues to outpace other health care sectors in deal volume despite the large price tags, propelled by favorable demographics, rising demand for care in the home, and the promise of cost savings.
Read more @ Hospice News